Singh A, Singh P. TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS. J. Drug Delivery Ther. 2016;6(5):97-102. doi:10.22270/jddt.v6i5.1303